Meropenem-d6(Synonyms: SM 7338-d6)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
Meropenem-d6 (Synonyms: SM 7338-d6)

Meropenem-d6 (SM 7338-d6) 是 Meropenem 的氘代物。Meropenem (SM 7338) 是一种具有广谱抗菌活性的碳青霉烯抗生素。Meropenem 对敏感和耐药的淋病奈瑟氏球菌 (MIC 值为 0.02-0.06 mg/mL)，流感嗜血杆菌 (MIC 值为 0.03-0.12 mg/mL) 和杜克氏杆菌 (MIC 值为 0.015-0.12 mg/mL) 具有活性。

Meropenem-d6(Synonyms: SM 7338-d6)

Meropenem-d6 Chemical Structure

CAS No. : 1217976-95-8

规格 是否有货
1 mg Check price and availability
10 mg Check price and availability

* Please select Quantity before adding items.

生物活性

Meropenem-d6 (SM 7338-d6) is the deuterium labeled Meropenem. Meropenem (SM 7338) is a carbapenem antibiotic with broad-spectrum antibacterial activity. Meropenem has activity against susceptible and resistant N. gonorrhoeae (MIC value of 0.02-0.06 mg/mL), H. influenzae (MIC value of 0.03-0.12 mg/mL), and H. ducreyi (MIC value of 0.015-0.12 mg/mL)[1][2].

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

389.50

Formula

C17H19D6N3O5S
CAS 号

1217976-95-8
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. L Slaney, et al. In-vitro activity of meropenem against Neisseria gonorrhoeae, Haemophilus influenzae and H. ducreyi from Canada and Kenya. J Antimicrob Chemother. 1989 Sep;24 Suppl A:183-6.

    [3]. George G Zhanel, et al. Comparative review of the carbapenems. Drugs. 2007;67(7):1027-52.

    [4]. Umit Ateskan, et al. Deferoxamine and meropenem combination therapy in experimental acute pancreatitis. Pancreas. 2003 Oct;27(3):247-52.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务